CLINICAL_TRIALS
trial_result
· 2025-09-11
Clinical Trial Update: Residual Inhibition of 40 Hz Burst Sound in Tinnitus Patients [NA]
Summary
This clinical trial evaluated residual inhibition of tinnitus using a 40 Hz burst sound. The study status is COMPLETED.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Tinnitus | NA | Status: COMPLETED